Literature DB >> 32741082

OMIP-068: High-Dimensional Characterization of Global and Antigen-Specific B Cells in Chronic Infection.

Katherine Cascino1, Mario Roederer2, Thomas Liechti2.   

Abstract

This 24-color flow cytometry panel focuses on characterizing antigen-specific B cells and precise delineation of B-cell subsets in chronic infections and is applicable to other chronic diseases such as autoimmunity. The panel was optimized for human cryopreserved peripheral blood mononuclear cells (PBMCs). Markers were chosen to extensively distinguish B-cell lineages (CD19, CD20, CD10, CD38, CD24, IgM, IgD, CD27, CD21, CD43, CD5). Inclusion of antigen-specific probes was of high priority in order to assess hepatitis B virus (HBV) antigen-specific B cells for our purposes. These probes can be readily exchanged for other pathogen-specific probes or additional markers for the panel to be tailored to desired research questions beyond HBV. In addition, we included a comprehensive and unique set of functional markers such as chemokine receptors (CXCR3, CXCR5), co-stimulatory molecule (CD86), Fc receptor (CD32), regulatory molecules (BTLA, CD39), and inhibitory markers associated with chronic infections (PD-1, FcRL5, CD11c, CD22) to enable in-depth analysis of global and antigen-specific B cells during chronic infection.
© 2020 International Society for Advancement of Cytometry. © 2020 International Society for Advancement of Cytometry.

Entities:  

Keywords:  B cells; HBV; antigen-specific B cells; chronic Infections; memory B cells; phenotyping

Mesh:

Substances:

Year:  2020        PMID: 32741082      PMCID: PMC7581549          DOI: 10.1002/cyto.a.24204

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  48 in total

Review 1.  Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.

Authors:  M Perez-Andres; B Paiva; W G Nieto; A Caraux; A Schmitz; J Almeida; R F Vogt; G E Marti; A C Rawstron; M C Van Zelm; J J M Van Dongen; H E Johnsen; B Klein; A Orfao
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

2.  To B1 or not to B1: that really is still the question!

Authors:  Stuart G Tangye
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

Review 3.  Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.

Authors:  Rohit Loomba; T Jake Liang
Journal:  Gastroenterology       Date:  2017-02-20       Impact factor: 22.682

Review 4.  Memory B cells.

Authors:  Tomohiro Kurosaki; Kohei Kometani; Wataru Ise
Journal:  Nat Rev Immunol       Date:  2015-02-13       Impact factor: 53.106

5.  Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg).

Authors:  F Figueiró; L Muller; S Funk; E K Jackson; A M O Battastini; T L Whiteside
Journal:  Oncoimmunology       Date:  2016-02-26       Impact factor: 8.110

6.  Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Authors:  Scott A Jenks; Kevin S Cashman; Esther Zumaquero; Urko M Marigorta; Aakash V Patel; Xiaoqian Wang; Deepak Tomar; Matthew C Woodruff; Zoe Simon; Regina Bugrovsky; Emily L Blalock; Christopher D Scharer; Christopher M Tipton; Chungwen Wei; S Sam Lim; Michelle Petri; Timothy B Niewold; Jennifer H Anolik; Greg Gibson; F Eun-Hyung Lee; Jeremy M Boss; Frances E Lund; Ignacio Sanz
Journal:  Immunity       Date:  2018-10-09       Impact factor: 31.745

Review 7.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

8.  Somatic hypermutation in peritoneal B1b cells.

Authors:  Bishnudeo Roy; Swati Shukla; Marcin Łyszkiewicz; Martina Krey; Nuno Viegas; Sandra Düber; Siegfried Weiss
Journal:  Mol Immunol       Date:  2009-03-26       Impact factor: 4.407

9.  PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Authors:  Loghman Salimzadeh; Nina Le Bert; Charles-A Dutertre; Upkar S Gill; Evan W Newell; Christian Frey; Magdeleine Hung; Nikolai Novikov; Simon Fletcher; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-08-07       Impact factor: 14.808

10.  Circulating and intrahepatic antiviral B cells are defective in hepatitis B.

Authors:  Alice R Burton; Laura J Pallett; Laura E McCoy; Kornelija Suveizdyte; Oliver E Amin; Leo Swadling; Elena Alberts; Brian R Davidson; Patrick Tf Kennedy; Upkar S Gill; Claudia Mauri; Paul A Blair; Nadege Pelletier; Mala K Maini
Journal:  J Clin Invest       Date:  2018-08-09       Impact factor: 19.456

View more
  2 in total

1.  Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.

Authors:  Rita Carsetti; Francesco Corrente; Claudia Capponi; Mattia Mirabella; Simona Cascioli; Patrizia Palomba; Valentina Bertaina; Daria Pagliara; Manuela Colucci; Eva Piano Mortari
Journal:  Cytometry A       Date:  2021-12-01       Impact factor: 4.714

2.  Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination.

Authors:  M Christian Tjiam; Sonia Fernandez; Martyn A French
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.